BioInfra Life Science (XKRX:266470) Scaled Net Operating Assets : 0.45 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BioInfra Life Science Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioInfra Life Science's operating assets for the quarter that ended in Dec. 2024 was ₩3,394.1 Mil. BioInfra Life Science's operating liabilities for the quarter that ended in Dec. 2024 was ₩2,224.1 Mil. BioInfra Life Science's Total Assets for the quarter that ended in Dec. 2023 was ₩2,602.5 Mil. Therefore, BioInfra Life Science's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.45.

BioInfra Life Science Scaled Net Operating Assets Historical Data

The historical data trend for BioInfra Life Science's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInfra Life Science Scaled Net Operating Assets Chart

BioInfra Life Science Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.20

-0.29

-0.07

-0.28

0.45

BioInfra Life Science Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial				-0.20	-0.29	-0.07	-0.28	0.45

Competitive Comparison of BioInfra Life Science's Scaled Net Operating Assets

For the Biotechnology subindustry, BioInfra Life Science's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioInfra Life Science's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioInfra Life Science's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BioInfra Life Science's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

BioInfra Life Science Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioInfra Life Science's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(3394.098	-	2224.148)	/	2602.454
=	0.45

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5473.01	-	2078.912
=	3394.098

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2431.556	-	0	-	207.408
=	2224.148

BioInfra Life Science's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(3394.098	-	2224.148)	/	2602.454
=	0.45

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5473.01	-	2078.912
=	3394.098

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2431.556	-	0	-	207.408
=	2224.148

BioInfra Life Science Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BioInfra Life Science's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInfra Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInfra Life Science Inc (XKRX:266470) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Daehak-ro 49, 7th Floor, Jongno-gu, Seoul, KOR, 03127

Website

http://www.bioinfra.co.kr

BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

BioInfra Life Science Headlines

No Headlines